RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Oct 7, 2026 · Director HERSHBERG ROBERT sold 25K Class A Common Stock at $5.00/unit ($125K); exercised options for 50K shares

Director HERSHBERG ROBERT sold 25K Class A Common Stock at $5.00/unit ($125K); exercised options for 50K shares

FORM 4

xslF345X06/wk-form4_1791410900.xmlSEC.gov

Graphics and non-inline formats (not embedded below).